Anaerobic Digestion Disinfection Patents: Leaders & White Space 2026
- Thin but concentrated field. only 21 patent families sit at the intersection of anaerobic digestion and digestate sanitization, so a handful of documents shape the whole claim map.
- Filing peaked in 2018 and has not recovered. activity hit 6 families that year, then fell back toward zero by the dataset midpoint — this is a mature, not a growing, claim space.
- One 1990s-era patent still anchors the field. US6047768A carries 37 citations, far more than any later filing, meaning newer entrants are still designing around a two-decade-old process claim.
A small, thermally-focused corner of digestate treatment
Anaerobic digestion disinfection patents cover the hardware and process claims for reducing pathogens in digestate before it leaves a biogas plant as fertiliser or soil amendment. The dataset is narrow — 21 families published between 2015 and mid-2026 — and it sits mostly inside water treatment and organic-fertiliser classifications rather than in sterilisation-specific codes. C02F (water and wastewater treatment) and C05F (organic and waste-derived fertilisers) between them cover nearly all of the corpus, which tells you the commercial framing is agricultural output quality, not medical-grade sterilisation.
Filing offices skew heavily toward the United States, with Europe, the PCT route and the UK trailing behind. Publication lags filing by roughly 18 months, so any apparent drop in the final year or two understates real activity — but the multi-year decline visible from the 2018 peak through the flat midpoint is a longer trend than that lag alone can explain.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 21-family dataset: activity over time, and where those families sit across the IPC scheme.
A 2018 peak that never returned
Filings rose to 6 in 2018, then declined toward the 2022 midpoint of zero before any later partial recovery. That pattern is consistent with a technology area where the core apparatus claims were staked out early and later filers have had less open space to claim into.
Water treatment and fertiliser codes dominate
C02F and C05F together account for the bulk of the corpus, with C12M bioreactor apparatus a distant third. Sterilisation-specific class A61L appears in only 2 records, confirming that most applicants frame digestate pathogen reduction as a wastewater or fertiliser-quality problem rather than a sterilisation one.
Shares are the percentage of the 21 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Anaerobic Digestion Disinfection with Eureka
This page is one run against one query. Ask Eureka your own question about anaerobic digestion disinfection and every answer comes back with the patent numbers behind it.
Try EurekaThe documents that set the boundaries
GB2509312A — pathogen reduction using process heat from biogas combustion
The filing describes an anaerobic digester paired with a boiler or CHP plant that combusts the biogas it produces, routing the resulting hot water and hot gases into a separate sanitization vessel that treats solid-state digestate. Valve-controlled heating circuits in the vessel walls and floor are run under a computerised protocol, so the sanitization step reuses combustion heat that would otherwise be a plant by-product.Filed by Andrew Richard Walsh, published 2014-07-02.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6047768A | Process and apparatus for treating waste | 37 |
| 2 | US8835155B2 | Biosolids digester and process for biosolids production | 9 |
| 3 | GB2509312A | Apparatus for achieving pathogen reduction in solid state anaerobic digestate utilizing process heat | 5 |
| 4 | US20200346989A1 | Biosolids digester and process for biosolids production | 3 |
| 5 | WO2011066393A2 | Biosolids digester and process for biosolids production | 3 |
| 6 | US20210024396A1 | Method of treating sludge | 2 |
| 7 | WO2019126117A1 | Method of treating sludge | 2 |
| 8 | US20140377855A1 | Biosolids digester and process for biosolids production | 2 |
Citation counts are drawn from this searched corpus and favour older filings; treat them as a signal of influence on later drafting, not of current commercial weight.
Publication numbers are shown where the record carries one (8 of 8 rows); clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers say about this field
Three findings that shape where new filings can still find open claim space.
Activity peaked early and has not rebuilt
The single busiest year in the dataset is 2018, with 6 families. By the 2022 midpoint, filing had fallen to zero, and it has not shown a sustained recovery since. For a field this small, that pattern points to the core apparatus and process claims having been staked out in the first half of the window.
One legacy patent still anchors the art
US6047768A, filed well before the rest of the corpus, carries 37 citations — more than four times the next most-cited record. Its continued pull suggests later filers, including the Biosolids digester family, are still drafting around process language it established.
Sterilisation framing is the minority approach
Only 2 records sit in A61L, the dedicated sterilising and disinfecting class. Most applicants instead file digestate pathogen-reduction claims as water treatment (C02F) or fertiliser (C05F) technology, which affects where a freedom-to-operate search needs to look.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to anaerobic digestion disinfection, with the prior art for and against each one.
A fragmented assignee base with no current momentum leader
With 21 families spread across a long list of assignees and only 8 co-assignee pairings, this is not a field with a single dominant filer. Recent-year activity across the named assignees, including Veolia Water Technologies, DVO and Upcycle & Co, all shows zero filings in the latest year — consistent with the broader flat-to-declining trend.
Collaboration is limited and localised
Co-filing pairs such as DVO Corporation with Stephen W. Dvorak, and Andrew R. Walsh with Celtic Bioenergy, each appear twice — the strongest pairings in the dataset. Most families, however, list a single assignee with no repeat partner.
The Biosolids digester lineage recurs across filings
Variants of the Biosolids digester and process for biosolids production appear multiple times in the most-cited list, spanning a granted US patent, a later US application and a WIPO PCT filing — a single technical lineage prosecuted across jurisdictions and time.
US filing dominates the receiving-office mix
Half of the corpus was filed at the USPTO, with Europe and the PCT route each accounting for 4 records and the UK and Austria contributing the remainder. Anyone assessing freedom to operate outside the US should not assume US findings transfer directly.
| Assignee | Recent year | YoY |
|---|---|---|
| Veolia Water Technologies Support | 0 | — |
| DVO Licensing, Inc. | 0 | — |
| DVO Corporation | 0 | — |
| Plateau Renewable Energy R&D Co., Ltd. | 0 | — |
| WALSH ANDREW R | 0 | — |
| UPCYCLE & CO INC | 0 | — |
| DVORAK STEPHEN W | 0 | — |
| CELTIC BIOENERGY | 0 | — |
Where to take this analysis
The dataset points to a narrow but settled claim space. These are the natural next questions for a team deciding whether to file, license or design around it.
Map freedom to operate against C02F and C05F, not just A61L
Because most digestate pathogen-reduction claims sit in water-treatment and fertiliser codes rather than sterilisation classes, a search confined to A61L will miss the bulk of the relevant art.
Run a freedom-to-operate search in EurekaTrace the Biosolids digester lineage across jurisdictions
The recurring Biosolids digester family spans granted US patents, a later US application and a PCT filing, making it a useful case study in how one technical concept was prosecuted internationally.
Pull the full family tree in EurekaTest claim language against the under-claimed branches
Continuous-flow sanitization and real-time pathogen sensing show little visible density in this corpus, which makes them worth a closer novelty check before committing R&D spend.
Draft and check claims in EurekaCommon questions on anaerobic digestion disinfection patents
In this dataset, digestate disinfection covers processes and apparatus that reduce pathogen loads in the solid or liquid output of an anaerobic digester, typically before it is applied as fertiliser or soil amendment. Most filings achieve this through thermal hygienization — heating the digestate to a target temperature for a set residence time — often using heat recovered from biogas combustion. The claims are classified mainly under water treatment (C02F) and organic fertiliser (C05F) codes rather than dedicated sterilisation classes, which matters when scoping a prior-art or freedom-to-operate search.
The dataset shows filing activity rising to 6 families in 2018, its highest point in the window covered, before declining toward zero by 2022. This is consistent with early entrants staking out core apparatus and process claims — such as combining a digester with a heat-recovery sanitization vessel — leaving less open claim space for later filers. Publication lag of roughly 18 months means the most recent one or two years will always look thinner than they eventually turn out to be, but the multi-year decline from 2018 is a longer pattern than lag alone explains.
The assignee base is fragmented: 21 families are spread across a long list of filers with only 8 co-assignee pairings, and none show recent filing momentum in the latest year covered. Notable names include DVO Corporation and its licensing entity, Veolia Water Technologies, and individual inventor-assignees such as Andrew R. Walsh working with Celtic Bioenergy. No single assignee holds a commanding share of the corpus, so competitive positioning here depends more on specific claim scope than on overall portfolio size.
GB2509312A describes an anaerobic digester paired with a boiler or CHP plant that combusts the biogas it produces, feeding the resulting hot water and gases into a separate sanitization vessel with valve-controlled heating circuits built into its walls and floor, run under computerised control. A design that reuses biogas combustion heat through a similarly structured, computer-controlled sanitization vessel risks overlapping this claim. Alternatives that avoid the specific heating-circuit and control architecture, such as different heat-transfer mechanisms or vessel geometries, are more likely to sit outside its scope, though a formal claim chart is needed before relying on that distinction.
The clearest gaps sit outside the dominant batch-and-thermal approach: continuous-flow sanitization vessels, real-time pathogen-load sensing with feedback control, and combined phosphate-recovery-plus-pathogen-reduction systems all show little visible claim density in this 21-family corpus. Heat-recovery integration specifically tuned to CHP exhaust streams, rather than generic hot water and gas circuits, is another under-claimed variant. Any of these would need a fresh novelty search given the field's small size, since a handful of new filings could materially change the picture.
Research Anaerobic Digestion Disinfection in depth with Eureka
Go past this page: query the whole anaerobic digestion disinfection corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.